Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MTA vs CEM Pulpotomy in Young Permanent Molars With a Diagnosis of Irreversible Pulpitis: A Randomized Clinical Trial

NCT04243733 is registered in ClinicalTrials.gov with Suez Canal University as lead sponsor.

NCT NCT04243733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04243733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MTA vs CEM Pulpotomy in Young Permanent Molars With a Diagnosis of Irreversible Pulpitis: A Randomized Clinical Trial
Lead sponsor
Suez Canal University
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2018
Completion date
January 10, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irreversible pulpitis